NewtekOne, Inc. Retires $95 Million of Senior Unsecured Notes BOCA RATON, Fla., Feb. 02, 2026 (GLOBE NEWSWIRE) -- (the “Company”) (NASDAQ: NEWT) retired $95 million of fixed rate senior notes that matured on February 1, 2026. The 5-year notes, which were publicly traded under the ticker symbol “NEWTZ”, were issued in 2021. The Company funded the $95.0 million repayment with $87.1 million of working capital and a recently completed exchange offer pursuant to which the Company exchanged $7.9 million of NEWTZ notes for a like amount of newly issued NEWTO notes. The NEWTZs were the last remn...
NewtekOne, Inc. Reports 4Q25 and Year-to-Date 2025 Basic and Diluted EPS of $0.65 and $0.65 and $2.21 and $2.18 Midpoint of 2026 Guidance Range is $2.35/Share BOCA RATON, Fla., Jan. 29, 2026 (GLOBE NEWSWIRE) -- NewtekOne, Inc. (the "Company") (Nasdaq: NEWT) reports its financial and operating results for the three and twelve month periods ended December 31, 2025. Financial Highlights for the three and twelve months ended December 31, 2025: For the three months ended December 31, 2025 ("4Q25"), basic and diluted earnings per share ("EPS") were $0.65 and $0.65, respectively, vs. $0.70 a...
NewtekOne, Inc. Reminds Investors of the Upcoming Fourth Quarter and Full Year 2025 Results Conference Call BOCA RATON, Fla., Jan. 26, 2026 (GLOBE NEWSWIRE) -- (the “Company”) (NASDAQ: NEWT) will report its fourth quarter 2025 financial results after the market closes on Thursday, January 29, 2026. A conference call to discuss these results will be hosted by Barry Sloane, Chief Executive Officer, and Frank M. DeMaria, Chief Financial Officer, at 4:30 pm ET on Thursday, January 29, 2026. Barry Sloane commented, “We are excited to release fourth quarter and full year 2025 earnings and to ...
NewtekOne, Inc. Announces the Expiration Final Results of Exchange Offer for its Outstanding 5.50% Notes due 2026 for its 8.50% Fixed Rate Senior Notes due 2031 and Waiver of Minimum Exchange Condition BOCA RATON, Fla., Jan. 23, 2026 (GLOBE NEWSWIRE) -- NewtekOne, Inc. (“NewtekOne”) today announced that its previously announced offer to exchange (the “Exchange Offer”) any and all of its 5.50% Notes due 2026 (the “Old Notes”) for its newly issued 8.50% Fixed Rate Senior Notes due 2031 (the “New Notes”) had expired as of 5:00 p.m., Eastern time on January 23, 2026 (the “Expiration Date”). A...
Acrivon Therapeutics Announces Late-Breaking Oral Presentation at Upcoming European Society of Gynecological Oncology (ESGO) Annual International Congress Globally recognized key opinion leader Panagiotis (Panos) Konstantinopoulos, M.D., Ph.D., Dana-Farber Cancer Institute, will highlight company’s recent interim clinical data from the ongoing, registrational-intent Phase 2b study of ACR-368 in subjects with endometrial cancer WATERTOWN, Mass., Jan. 23, 2026 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biotechnolog...
NewtekOne, Inc. Closes ALP Loan Securitization with Sale of $295 Million of Rated Notes Transaction Marks NewtekOne’s 17th and Largest Securitization BOCA RATON, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) -- (the “Company”) (NASDAQ: NEWT) announced today that it has closed a $295 million securitization backed by $342 million of Alternative Loan Program (“ALP”) loans. This securitization, NALP Business Loan Trust 2026-1 (“2026-1”), represents the Company’s fourth asset-backed securitization secured by ALP loans and is the Company’s 17th and largest rated securitization. All of the Company’s p...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.